AUROBINDO PHARMA
|
The Current P/B Ratio of AUROBINDO PHARMA is 2.71.
Share Price | ₹1,394.7 | Nov 06,2024 |
Market Cap | ₹81,001.3 Cr | |
Book Value | ₹29,842.8 Cr | Mar2024 - Consolidated Results |
Price/Book | 2.71x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of AUROBINDO PHARMA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹81,001.3 Cr] as on Nov 06,2024
(/) Book Value [ ₹29,842.8 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 2.71x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.71 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/B Ratio of AUROBINDO PHARMA over the last five years.
Historical PB (Price/Book ) ratio chart of AUROBINDO PHARMA
PB Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.73x.
- AUROBINDO PHARMA 's operated at median p/b ratio of 1.59x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/b ratio peaked in Mar2021 at 2.36x.
- AUROBINDO PHARMA 's p/b ratio hit its five-year low in Mar2023 of 1.13x.
How does AUROBINDO PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
AUROBINDO PHARMA | 29,842.80 | 2.71 | 81,001.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.89 | 438,418.0 |
CIPLA LTD | 26,619.90 | 4.84 | 128,755.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.87 | 108,720.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.05 | 100,120.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.62 | 157,680.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.80 | 110,181.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.84 | 108,624.0 |
LUPIN LTD | 14,175.80 | 6.97 | 98,759.4 |
ABBOTT INDIA LTD | 3,658.73 | 16.91 | 61,867.8 |
ALKEM LABORATORIES LTD | 10,292.50 | 6.80 | 69,979.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs AUROBINDO PHARMA 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.71x |
Max industry PB | 16.91x |
Median industry PB | 6.89x |
Average industry PB | 8.48x |
You may also like the below Video Courses